Loss of TMEM65 in mice causes mitochondrial disease mediated by mitochondrial Ca2+

Read full text
Authors: Yingfan Zhang, Hailey A. Parry, Laura Reyes, Alex Shamoun, Junhui Sun, Chengyu Liu, Danielle Springer, Audrey Noguchi, Sachiko Nakamori, Angel Aponte, Jeeva Munasinghe, Raúl Covián
+2 more Elizabeth Murphy, Brian Glancy
Cited by: 5
References: 54

Abstract

Abstract Transmembrane protein 65 (TMEM65) depletion in a patient caused severe mitochondrial encephalomyopathy, highlighting its clinical importance. Recent studies show TMEM65 acts as a mitochondrial Na + /Ca 2+ exchanger in vitro. Here, we generated conditional Tmem65 knockout mice to define its role in neuromuscular tissues in vivo. Both whole-body and nervous system–specific Tmem65 knockouts exhibited severe growth retardation and seizure-associated sudden death at ~3 weeks, establishing TMEM65 as indispensable for neuronal function. Additionally, skeletal muscle–specific knockout produced adult-onset myopathy preceded by elevated mitochondrial Ca 2+ . Consistently, TMEM65 ablation caused loss of Na + -dependent mitochondrial Ca 2+ export. Notably, blocking mitochondrial Ca 2+ entry by mitochondrial calcium uniporter (MCU) knockout rescued the early lethality of whole-body Tmem65 ablation, extending lifespan from ~3 weeks to >1 year. These data reveal an essential physiological role for TMEM65 and suggest that modulating mitochondrial Ca 2+ may offer therapeutic value for TMEM65 misexpression and other mitochondrial diseases associated with Ca 2+ overload.

Fields of Study & Subjects

Mitochondrial Function and Pathology Alzheimer's disease research and treatments ATP Synthase and ATPases Research

Publication details

Journal / source
Nature Communications
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Publication date
14 April 2026
Language
EN